Guide to the Long-Term Illness (LTI) Scheme

Similar documents
Medicines Formulary BNF Section 4 Central Nervous System

NI Formulary: Chapter 4 Central Nervous system

Medications used to treat Parkinson s disease

PARKINSON S MEDICATION

Drug Therapy of Parkinsonism. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Treatment of Parkinson s Disease and of Spasticity. Satpal Singh Pharmacology and Toxicology 3223 JSMBS

Common medicines given to neurology patients on discharge from hospital

Chapter 4 ~ Central nervous system

Parkinson s disease. Information for patients and carers. The Leeds Teaching Hospitals NHS Trust

History Parkinson`s disease. Parkinson's disease was first formally described in 1817 by a London physician named James Parkinson

Management of Epilepsy in Primary Care and the Community. Carrie Burke, Epilepsy Specialist Nurse

Lecture 5 Skeletal muscle relaxants. Pharmacologic management of parkinsonism and other movement disorders.

Appendix 2: Admissions checklists for people with Parkinson s

DRUGS THAT ACT IN THE CNS

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology

10th Medicine Review Course st July Prakash Kumar

Motor Fluctuations Stephen Grill, MD, PHD Parkinson s and Movement Disorders Center of Maryland and Johns Hopkins University

Updated advice for nurses who care for patients with epilepsy

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology

Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay

Epilepsy: pharmacological treatment by seizure type. Clinical audit tool. Implementing NICE guidance

Re-Submission. Scottish Medicines Consortium. rasagiline 1mg tablet (Azilect ) (No. 255/06) Lundbeck Ltd / Teva Pharmaceuticals Ltd.

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers

TOP APS DRUGS - DIVALPROEX SODIUM BRAND NAME: DEPAKOTE (ER)

Recent Advances in the cause and treatment of Parkinson disease. Anthony Schapira Head of Dept. Clinical Neurosciences UCL Institute of Neurology UCL

Communicating About OFF Episodes With Your Doctor

STOPP START Toolkit Supporting Medication Review in the Older Person

Summary of Patient < 3y at Visit 11 (90 months)

The Epilepsy Prescriber s Guide to Antiepileptic Drugs

Answer ALL questions. For each question, there is ONE correct answer. Use the answer grid provided for ALL your answers.

Drug Management of Parkinsonism. By Prof. Mohammad Saleh M. Hassan PhD. (Pharma); MSc. (Ped.); MHPE (Ed.)

Back to Basics: The Basics of Medication Monitoring

Anticholinergics. COMT* Inhibitors. Dopaminergic Agents. Dopamine Agonists. Combination Product

Critical Time Medication Procedure

CHRONIC MEDICINE PROGRAMME: GENERAL INFORMATION LETTER

Safe transfer of prescribing guidance

Drugs Affecting the Central Nervous System

Best Medical Treatments for Parkinson s disease

Parkinson s Disease Medications: Professionals Edition

Anticonvulsants Antiseizure

XADAGO (safinamide) oral tablet

DRUGS, PREGNECY & NEWBORN

Management of Parkinson s Disease in Primary and Secondary care for patients with compromised swallow or those patients deemed Nil By Mouth.

Faculty of dentistry Second year CND Course CNS Drugs Dr. Ali Awadallah

The symptoms of the Parkinson s disease may vary from person to person. The symptoms might include the following:

Parkinson s Disease. Gillian Sare

Chapter 4 Central Nervous System

Chapter 4 ~ Central nervous system

ACUTE MANAGEMENT OF PARKINSON S PATIENTS WHO ARE NIL BY MOUTH (NBM) OR WHO HAVE A COMPROMISED SWALLOW NHS LANARKSHIRE PARKINSON S TEAM

Epilepsy 101. Overview of Treatment Kathryn A. O Hara RN. American Epilepsy Society

Therapeutic Drugs Monitoring TDM 2018 Therapeutic Drugs Monitoring Scheme Application Form

Inventory of paediatric therapeutic needs

Drug Classifications

Parkinson s disease Therapeutic strategies. Surat Tanprawate, MD Division of Neurology University of Chiang Mai

CHRONIC MEDICINE PROGRAMME GENERAL INFORMATION LETTER

Pharmacology. An Introduction. Henry Hitner, Ph.D. Barbara Nagle, Ph.D. Learn. Neuroscience, Physiology,

Polypharmacy: Guidance for Prescribing in Frail Adults

Seizure medications An overview

CHRONIC MEDICINE PROGRAMME: PICK N PAY PLUS OPTION - GENERAL INFORMATION LETTER

Supplementary Online Content

ANTIEPILEPTIC Medicines

APPENDIX K Pharmacological Management

Parkinson s Disease Current Treatment Options

Epilepsy Society Therapeutic Drug Monitoring Unit (TDM Unit) Chalfont Centre for Epilepsy Chesham Lane Chalfont St Peter Buckinghamshire, SL9 ORJ

APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline

CHRONIC TREATMENT GUIDELINES

Chapter 2 ~ Cardiovascular system

WITBANK COALFIELDS MEDICAL AID SCHEME (WCMAS) CHRONIC MEDICINE PROGRAMME GENERAL INFORMATION LETTER

Disclosure. Learning Objectives

Ernie Somerville Prince of Wales Hospital EPILEPSY

Presented by Meagan Koepnick, Josh McDonald, Abby Narayan, Jared Szabo Mentored by Dr. Doorn

Generic Name (Brand Name) Available Strengths Formulary Limits. Primidone (Mysoline) 50mg, 250mg -- $

BC Cancer Agency & Canadian Cancer Society Financial Support Drug Program (FSDP) for Cancer Patients. Drug Benefit List. Updated August 1, 2017

Medicines for chronic kidney disease

Margo J Nell Dept Pharmacology

CoQ10/Ubiquinol- Statin medications deplete this valuable nutrient.

Appendix. TABLE E-1 Study Variables and Associated ICD-9-CM, HCPCS, and CPT Codes. Codes. (1) Fracture locations

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Drugs used in Parkinsonism

Pharmacology 260 Online Course Schedule Summer 2015

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

parts of the gastrointenstinal tract. At the end of April 2008, it was temporarily withdrawn from the US Market because of problems related to

MEDICATION GUIDE DUOPA (Do-oh-pa) (carbidopa and levodopa) enteral suspension

Novel approaches to the pharmacological treatment of Parkinson s disease. Peter Jenner King s College UK

ANTICONVULSANT STEP THERAPY

Guideline for the Management of Parkinson s Disease Medication Trust Reference B26/2017

MANAGEMENT OF PATIENTS WITH PARKINSON S DISEASE WHO ARE NIL BY MOUTH OR WITH A COMPROMISED SWALLOW

Package leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium

A. Incorrect! Seizures are not typically linked to alcohol use. B. Incorrect! Epilepsy is a seizure that is commonly associated with convulsions.

STOPP and START criteria October 2011

Medications to Expedite Rehabilitation of the Traumatic Brain Injury Patient

Advanced Therapies for Motor Symptoms in PD. Matthew Boyce MD

Transcription:

Guide to the Long-Term Illness (LTI) Scheme 1

Contents What is the Long-Term Illness (LTI) scheme? What are the diseases and disabilities covered by the LTI scheme? How do I find out if I am entitled to the LTI scheme? What happens if a doctor prescribes medicines or equipment to treat a specified disease or disability and they are not on the list of approved items? Will I have to pay a prescription charge for my medicines? What drugs, aids and appliances are free under the LTI scheme? Illness code A: Intellectual disability (This is described in legislation as mental handicap.) Illness code B: Hydrocephalus Illness code C: Cerebral palsy Illness code D: Muscular dystrophy Illness code E: Haemophilia Illness code F: Diabetes mellitus type 1 and type 2 Illness Code G: Diabetes insipidus Illness code H: Epilepsy Illness Code J: Multiple sclerosis Illness code K: Parkinsonism Illness code L: Cystic fibrosis Illness Code M: Phenylketonuria (PKU) 3 4 5 5 5 6 7 8 9 10 10 11 12 13 14 15 16 17 Illness code N: Acute leukaemia Illness code P: Mental Illness: (only for people aged under 16 years) Illness code Q: Spina bifida Illness code R: Thalidomide 17-18 18 19 19 2

What is the Long-Term Illness (LTI) scheme? The Long-Term Illness (LTI) scheme is a community health scheme. It means that people who are diagnosed with a specified longterm disease or disability can get a range of medicines from their community pharmacy free. You must first establish that you qualify for this scheme through the Health Service Executive (HSE). You do this by submitting the Long-Term Illness Application Form to your local HSE Community Health Organisation. Certain aids and appliances for example insulin pumps are also available from your local HSE Community Health Organisations. 3

What are the diseases and disabilities covered by the LTI scheme? Your doctor can register an appeal with the HSE Community Health Organisation in your locality. In an appeal, you must provide clear evidence of the link between alternative prescribed drugs, medicine and appliances to those on the approved list. These diseases and disabilities are covered by the LTI scheme Illness Code A. B. C. D. E. F. G. H. J. K. L. M. N. Q. P. R. Diseases and disabilities Intellectual disability. This is described in legislation as 'mental handicap'. Hydrocephalus. Cerebral palsy. Muscular dystrophy. Haemophilia. Diabetes mellitus. Diabetes insipidus. Epilepsy. Multiple sclerosis. Parkinsonism. Cystic fibrosis. Phenylketonuria (PKU). Acute leukaemia. Spina bifida. Mental Illness only for people under the age of 16 years. Thalidomide for conditions arising from the use of this drug. 4

How do I find out if I am entitled to the LTI scheme? You must first complete a Long-Term Illness (LTI) Application Form and send it to the HSE Community Health Organisation in your area. LTI Application Forms are available from the HSE Community Health Organisation in your area or the Citizen Information Centres. Or, you can download a LTI Application Form from the HSE website at: www.hse.ie/ltiform When we have approved your application to benefit from the LTI scheme, we will send you a LTI card. Your community pharmacist will then be able to confirm that you are entitled to benefit from the LTI scheme. Aids and appliances If you need particular aids and appliances to treat a specified disease or disability, we will make them available to you in certain circumstances. You must apply for these to the HSE Community Health Organisation in your area. What happens if a doctor prescribes medicines or equipment to treat a specified disease or disability and they are not on the list of approved items? If your doctor thinks you need medicines or equipment that are not on the list of approved items for your LTI condition, you can appeal to the HSE Community Health Organisation in your area. In that appeal, your doctor must provide clear evidence showing the link between the medicines or equipment they are requesting and your LTI condition. Will I have to pay a prescription charge for my medicines? No. You do not have to pay a prescription charge for medicines prescribed to you to treat a specified disease or disability listed under the LTI scheme. 5

What drugs, aids and appliances are free under the LTI scheme? The following pages list (in alphabetical order) the products that are included in the LTI scheme. Your doctor and pharmacist also have these lists and know that only the products on these lists are available free-of-charge. 6

Illness code A: Intellectual disability. This is described in legislation as 'mental handicap'. Antibiotics. Anticonvulsants, including benzodiazepines used for this purpose. Asthma preparations. Corticosteroids. Domperidone syrup. Drugs for cardiac (heart) problems, for example: furosemide, spironolactone. Giving sets, for example, for tube feeding. Histamine H2 blockers and proton-pump inhibitors. Hypnotics (drugs to help you sleep). Laxatives. Needles and syringes. Water for injection. 7

Illness code B: Hydrocephalus Antibiotics. Anticonvulsants, including benzodiazepines used for this purpose. Bags: leg bags, drainage bags, and catheters (tubes). Barrier creams. Corticosteroids. Dressings. Hypnotics (drugs to help you sleep). Needles and syringes. Urinary antiseptics. Water for injection. 8

Illness code C: Cerebral palsy Antibiotics. Anticonvulsants, including benzodiazepines used for this purpose. Bags: leg bags, drainage bags, and with integral catheters (tubes). Barrier creams. Catheters. Disposable gloves. Domperidone syrup. Histamine H2 blockers and proton-pump inhibitors. Hypnotics (drugs to help you sleep). KY Jelly. Laxatives. Muscle relaxants including: baclofen, dantrolene, and tizanidine. Needles and syringes. Treatment for osteoporosis. Urinary sheaths. Water for injection. 9

Illness code D: Muscular dystrophy Antibiotics. Bags: leg bags, drainage bags, and with integral catheters (tubes). Barrier creams. Dressings. Muscle relaxants including: baclofen, dantrolene, and tizanidine. Needles and syringes. Treatments for osteoporosis. Urinary antiseptics. Water for injection. Illness code E: Haemophilia Blood products. 10

Illness code F: Diabetes mellitus - type 1 and type 2 Alpha-glucosidase inhibitor acarbose. Anti-hypertensives, including diuretics. Aspirin. Biguanides. Consumable items like sensors required for use with insulin pumps. Control solutions for use with meters. Dextrose gel. DPP-4 inhibitors, for example: sitagliptin, saxagliptin, and vildagliptin. Glucagen hypokit. Injection swabs. Insulin needles and syringes. Insulins. Lancets. Lipid lowering drugs including: statins, fibrates, and exetimibe. Liraglutide and exenatide injections. Nateglinide and repaglinide. Sulphonylureas. Test strips including: blood glucose test strips, and urine test strips. Meters are not included. Thiazolidinediones. Warfarin and new oral anticoagulants. 11

Illness code G: Diabetes insipidus Desmopressin tablets injections and nasal sprays. Potassium supplements, for example: Kay-Cee-L syrup, and Slow K tablets. 12

Illness code H: Epilepsy Acetazolamide. Carbamazepine. Carbonic anhydrase inhibitors. Clobazam. Clonazepam. Diazepam. Ethosuximide. Folic acid. Gabapentin. Lacosamide. Lamotrigine. Levetiracetam. Midazolam. Oxycarbazepine. Phenobarbitone. Phenytoin. Pregabalin. Primidone. Rufinamide. Sodium valproate. Tiagabine. Topiramate. Vigabatrin. Zonisamide. 13

Illness code J: Multiple sclerosis Analgesics. Antibiotics. Antidepressants. Anxiolytics and hypnotics. Bags including: leg bags, and drainage bags. Catheters (tubes) and urinary sheaths. Corticosteroids. Diaminopyridine 3, 4. Only when you have a prescription from a hospital consultant. Disposable gloves. Gabapentin. Instillagel. KY jelly. Lamotrigine. Laxatives. Muscle relaxants including: baclofen, tizanidine, and dantrolene. Naltrexone. Naudicelle (Plain or Plus) capsules. Osteoporosis treatments. Pregabalin. Urinary antiseptics. Urinary frequency medicines including: antispasmodics, and anticholinergics. Water for injection; and needles and syringes. 14

Illness code K: Parkinsonism Amantadine. Anti-cholinergic drugs, for example: procyclidine, and biperiden. Antidepressants. Apomorphine. Catechol-o-methyl transferase (COMT) inhibitors, for example: entacapone, and tolcapone. Dopamine precursor and dopa decarboxylase inhibitors, for example: levodopa and benserazide, and levodopa and carbidopa. Dopamine precursor: for example: dopa decarboxylase inhibitor, and COMT inhibitors. Dopamine receptor agonists, for example: bromocriptine. cabergoline, pergolide, pramipexole, ropinirole, and rotigotine. Laxatives. Levodopa. Monoamine oxidise- B (MAO-B) inhibitors, for example: rasagiline, and selegiline. Scopoderm patches only when you have a prescription from a hospital consultant. 15

Illness code L: Cystic fibrosis Antacids, H2 antagonists, and proton pump inhibitors. Antibiotics. B2 agonists, for example: inhalers, and diskhalers. These can be in the form of tablets or nebulised. Corticosteroids. Dispoable equipment including: gloves, and facemasks. Giving sets (for example, for tube feeding). Injections of: hepsal, heprinse, heplok, and heparin. Ketovite tablets or liquid. Laxatives. Mucolytics. Pancreatic enzymes. Paracetamol. Sodium chloride injections. Syringes and needles. Vitamins: adeks or aquadeks vitamins, and other prescribed fat-soluble vitamins. Water for injection. 16

Illness code M: Phenylketonuria (PKU) Ketovite tablets or liquid. Prescribed low-protein clinical nutrition products. Illness code N: Acute leukaemia Acyclovir. Allopurinol tablets. Anti-fungals oral. Anti-ulcer drugs. Antibiotics. Azathioprine tablets. Catheters. Chemotherapy anti-emetics (anti-nausea), for example: ondansetron, and granisetron. Cytotoxic drugs for acute leukaemia. Disposable gloves. Domperidone in the form of: tablets, syrup, or suppositories Famciclovir tablets. Flushing solution, for example: hepsal, heprinse, and heplock. Folic acid. Injection swabs. 17

Illness code N: Acute leukaemia (Continued) Instillagel or EMLA cream. Lactulose. Metoclopromide Mouthwash: Corsodyl, and Oraldene. Nasogastric tubes and 'giving sets'. Pain killers: ibuprofen, diclofenac, and paracetamol. Prescribed dressings. Steroids. Syringes and needles. Urinary antiseptics. Valaciclovir tablets. Water for injection. Illness code P: Mental Illness (only for people aged under 16 years) Melatonin (when consultant gives first prescription and continues supervision). Methylphenidate (when consultant gives first prescription and continues supervision). Modafinil (when consultant gives first prescription and continues supervision). SSRIs (when consultant gives first prescription and continues supervision). 18

Illness code Q: Spina bifida Antibiotics. Bags: leg bags, and drainage bags. Barrier creams. Catheters (tubes). Disposable gloves. Dressings. Folic acid. KY Jelly. Laxatives. Prescribed analgesics (painkillers). Treatment for osteoporosis. Urinary antiseptics. Illness code R: Thalidomide Medicines for conditions arising from the use of thalidomide. 19

You can get more information by: calling LoCall 1890 252 919; or go to www.hse.ie/lti Published: LTI May 2017 20